生命科学相关产品
Search documents
争光股份:公司在自主研发的基础上,加大与科研院所的合作
Zheng Quan Ri Bao Zhi Sheng· 2026-02-09 11:45
Core Viewpoint - The company is focusing on enhancing its product series and expanding into new application areas by collaborating with research institutions and responding to market demands [1] Group 1 - The company aims to achieve breakthroughs in fields such as life sciences, semiconductors, rare and precious metal separation and extraction, and nuclear-grade resins [1] - The company emphasizes its commitment to comply with relevant laws and regulations regarding information disclosure [1] - The company will announce any significant matters that meet disclosure standards in a timely manner [1]
利安隆:通过“抗老化剂+润滑油添加剂+生命科学”多业务协同形成抗风险能力
Quan Jing Wang· 2025-09-11 13:25
Core Viewpoint - The company has achieved revenue and profit growth in the first half of 2025, demonstrating resilience against changes in the international business environment and maintaining a strategic focus [1] Financial Performance - In the first half of 2025, the company reported a revenue of 2.995 billion yuan and a net profit attributable to shareholders of 241 million yuan [1] - The net profit after deducting non-recurring gains and losses was 236 million yuan [1] Business Strategy - The company has maintained a compound annual growth rate (CAGR) of 24.59% in revenue over the past fourteen years [1] - The company employs a multi-business collaboration strategy involving "anti-aging agents + lubricant additives + life sciences" to enhance its risk resistance [1] - The company is actively planning a dual-track development model focusing on both product and capacity expansion overseas, promoting new products, new fields, and new production locations [1] Operational Focus - The company is accelerating its development in automation, information technology, and intelligence while ensuring the safety and health of its employees [1] - The company aims to achieve its annual "Big 3+1" goal through the collective efforts of all employees [1]